PROPOSED RULES
Original Notice.
Preproposal statement of inquiry was filed as WSR 09-22-089.
Title of Rule and Other Identifying Information: WAC 260-70-630 Threshold levels.
Hearing Location(s): Auburn City Council Chambers, 25 West Main, Auburn, WA 98002, on March 9, 2012, at 9:30 a.m.
Date of Intended Adoption: March 9, 2012.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, e-mail dmoore@whrc.state.wa.us, fax (360) 459-6461, by March 6, 2012.
Assistance for Persons with Disabilities: Contact Patty Sorby by March 6, 2012, TTY (360) 459-6462.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: Removes the restriction that jockeys may not own horses and allows them to own with certain restrictions.
Reasons Supporting Proposal: Ensures transparency for stakeholders and the public on true ownership of horses.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: [Horse racing commission], governmental.
Name of Agency Personnel Responsible for Drafting: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462; Implementation and Enforcement: Robert J. Lopez, 6326 Martin Way, Suite 209, Olympia, WA 98516-5578, (360) 459-6462.
No small business economic impact statement has been prepared under chapter 19.85 RCW. Not applicable.
A cost-benefit analysis is not required under RCW 34.05.328. Not applicable.
January 11, 2012
Douglas L. Moore
Deputy Secretary
OTS-4558.1
AMENDATORY SECTION(Amending WSR 08-17-051, filed 8/14/08,
effective 9/14/08)
WAC 260-70-630
Threshold levels.
(1) Permitted
medications.
(a) The following quantitative medications are permissible in test samples up to the stated concentrations:
Procaine - 25 ng/ml urine
Benzocaine - 50 ng/ml urine
Mepivacaine - 10 ng/ml urine
Lidocaine - 50 ng/ml urine
Bupivacaine - 5 ng/ml urine
Clenbuterol - 25 pg/ml serum or plasma
Acepromazine - 25 ng/ml urine
Promazine - 25 ng/ml urine
Salicylates - 750,000 ng/ml urine
Albuterol - 1 ng/ml urine
Pyrilamine - 50 ng/ml urine
Theobromine - 2000 ng/ml urine
Methocarbamol - 1 ng/ml serum or plasma
Glycopyrrolate - 3.5 pg/ml serum or plasma
DMSO - 10 mc/ml serum or plasma
Firocoxib - 40 ng/ml serum or plasma
(b) The official urine or blood test sample may not contain more than one of the above substances, including their metabolites or analogs, and may not exceed the concentrations established in this rule.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Caffeine - 100 ng/ml serum or plasma
Benzoylecgonine - 50 ng/ml urine
Morphine Glucuronides - 50 ng/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
Stanozolol (Winstrol) - 1 ng/ml urine in all horses regardless of sex.
Boldenone (Equipoise) - 15 ng/ml urine in intact males. No level is permitted in geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3&bgr;,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.
[Statutory Authority: RCW 67.16.020 and 67.16.040. 08-17-051, § 260-70-630, filed 8/14/08, effective 9/14/08; 08-05-091, § 260-70-630, filed 2/15/08, effective 6/1/08; 06-09-009, § 260-70-630, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-630, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. 04-05-095, § 260-70-630, filed 2/18/04, effective 3/20/04; 03-11-019, § 260-70-630, filed 5/12/03, effective 6/12/03. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-630, filed 4/17/96, effective 5/18/96.]